$1,499.00
Quantity: ~1M viable cells
CIRM Line ID: CW60130
Disease: Epilepsy
Gender: Female
Sampled age: 6
Ethinicity: Caucasian, not Latino
Description
Quantity: ~1M viable cells
CIRM Line ID: CW60130
Disease: Epilepsy
Gender: Female
Sampled age: 6
Race: Caucasian, not Latino
Donor data
Demographic (source: CIRM) | Description | EPILEPSY |
Affected Status | Yes | |
Product | iPSC | |
Source | PBMC | |
Sex | Male | |
Age at Sampling | 6 YR | |
Race | Caucasian | |
Ethnicity | Not Hispanic or Latino | |
Publications Cited | 0 | |
dbGap | No | |
Biopsy Source | Blood | |
Collection | Neurodevelopmental Disorders | |
Remarks | Height percentage < 5% | |
Cell Type | Stem Cell | |
Tissue Type | Induced pluripotent stem cell | |
Transformant | Episomal | |
Species | sapiens | |
Common Name | human | |
Detailed Clinical Data | false | |
Clinical data (source: CIRM) | Age_at_first_seizure | 4 |
Age_units | Years | |
Age_at_last_seizure | 5 years | |
Seizure_type | Absence | |
Seizures_with_fever? | No | |
Seizures_without_fever? | Yes | |
Being_treated_for_seizures_now? | Yes | |
EEG_findings | Focal sharp waves |
- Users do not need any additional license for the use of these differentiated cells even when cells are used for high throughput screening or drug discovery.
- All donor consents include statements on the following:
- Testing the cells’ DNA (this is referred to as the cell’s genetic code or sequence) and making the information known to other researchers
- Changing some of the genetic code or sequence within these cells
- Using cells to test or select drugs to treat disease
- Transplanting cells or resulting products to humans or animals
Distributing cells widely (nationally and internationally) for research, training or commercial medical product development
- Future research and uses unforeseen at this time
- Donors were screened and negative for HIV, HBV, and HCV. Donors under the age of 18 could opt out of HIV testing; all HCV-positive donors submitted skin punches, not peripheral blood, and were not screened for any infectious agents due to small volume of blood present in punches.
- Human induced pluripotent stem cells were established by non-integrating episomal reprogramming. Reprogramming and quality control were performed by Cellular Dynamics International.
Characteristics
Please refer this page for some characteristics data.